IL15 and neoplasm: The possibility to exploit microglial cells intranasally delivered as a source of IL-15 directly in the tumor mass could be an attractive alternative for GBM patient treatment, due to the high potential for clinical translatability, as one can obtain the microglia starting from patients’ iPSCs, as recently reported (46).